Newsfeeds - Spark Newswire

1 minute read

Watch Out: Inovio Pharmaceuticals Is Heating Up

August 12, 3:53 PM

Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares are trading higher Thursday alongside other vaccine maker stocks. Stocks have been trading higher recently as the COVIS-19 delta variant has been spreading throughout the U.S.

INO

7 minute read

85 Biggest Movers From Yesterday

By Lisa Levin

August 11, 5:14 AM

Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy adult volunteers.

ABVC

1 minute read

Why Inovio’s Stock Is Trading Lower Today

By Henry Khederian

August 10, 12:42 PM

Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are trading lower by 9.9% at $8.65 after the company reported worse-than-expected second-quarter EPS and sales results.

INO

4 minute read

54 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

August 10, 12:02 PM

Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) climbed 79.3% to $14.93 after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy adult volunteers.

ACI

1 minute read

Earnings

Recap: Inovio Pharmaceuticals Q2 Earnings

By Benzinga Insights

August 9, 5:21 PM

Shares of Inovio Pharmaceuticals (NASDAQ:INO) moved lower in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 95.00% year over year to ($0.39), which missed the estimate of ($0.25).

INO

1 minute read

Inovio Pharmaceuticals Q2 EPS $(0.39) Misses $(0.25) Estimate, Sales $272.82K Miss $1.21M Estimate

By Bill Haddad

August 9, 4:09 PM

Inovio Pharmaceuticals (NASDAQ:INO) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.25) by 56 percent. This is a 95 percent decrease over losses of $(0.20) per share from

INO

2 minute read

Movers

Analyzing Inovio Pharmaceuticals’s Unusual Options Activity

By Benzinga Insights

August 9, 12:17 PM

Inovio Pharmaceuticals (NASDAQ:INO) shares experienced unusual options activity on Monday. The stock price moved up to $9.84 following the option alert.

INO

3 minute read

INOVIO, Advaccine Receive Regulatory Allowance For 2 Heterologous Prime-Boost Clinical Trials In China Using INO-4800, INOVIO’s COVID-19 DNA Vaccine Candidate

By Benzinga Newsdesk

August 9, 8:05 AM

INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, today announced that

INO

14 minute read

Earnings Scheduled For August 9, 2021

By Benzinga Insights

August 9, 4:11 AM

Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million.

ACM

7 minute read

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

By Shanthi Rexaline

August 8, 10:03 AM

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.

ABCL